![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Bladder Cancer |
| Single Articles |
AMEDEO Bladder Cancer is free of charge.
Disassembly of Extracellular Matrix and Intercellular Adhesion Enables
Noninvasive Bladder Cancer Disaggregation.
ACS Nano. 2026;20:31123-31136.
PubMed
Abstract available
Retraction of: Circular RNA circRGNEF promotes bladder cancer progression via
miR-548/KIF2C axis regulation.
Aging (Albany NY). 2026;18:1529.
PubMed
A Self-Confined Rotational Hydrogel Chemiluminescence Motor Array for Rapid and
Sensitive Detection of Bladder Cancer Biomarkers.
Anal Chem. 2026;98:33328-33337.
PubMed
Abstract available
Preoperative Renal Impairment as an Independent Determinant of Poor Survival
After Concomitant Laparoscopic Radical Cystectomy and Nephroureterectomy.
Ann Surg Oncol. 2026;33:11644-11653.
PubMed
Abstract available
Statement of Retraction: Neurexophilin 4 is a prognostic biomarker correlated
with immune infiltration in bladder cancer.
Bioengineered. 2026;17:2749381.
PubMed
A urea-powered platelet micromotor initiates self-amplifying ECM remodeling to
potentiate BCG immunotherapy in bladder cancer.
Biomaterials. 2026;339:124784.
PubMed
Abstract available
Nonsteroidal anti-inflammatory drug use and site-specific risk of urological
cancers: a systematic review and meta-analysis.
BMC Cancer. 2026;26:1471.
PubMed
Abstract available
Real-world patterns of first-line treatment selection after the introduction of
enfortumab vedotin plus pembrolizumab for advanced urothelial carcinoma.
BMC Cancer. 2026;26:1470.
PubMed
Abstract available
CD22 and CD79A expression level in bladder cancer patients using bioinformatics
tools, RNA-Seq and qRT-PCR validation.
BMC Cancer. 2026;26:1419.
PubMed
Abstract available
Preoperative frailty and multidimensional concurrent correlates among older
adults scheduled for radical cystectomy: a social ecological model-informed
cross-sectional study.
BMC Urol. 2026;26:295.
PubMed
Abstract available
Impact of pioglitazone use on clinicopathological features and aggressiveness of
bladder cancer: a retrospective cohort study.
BMC Urol. 2026;26:304.
PubMed
The prognostic impact of variant histology timing in bladder cancer: a
comparative analysis of primary and secondary detection.
BMC Urol. 2026;26:300.
PubMed
Abstract available
Cell-free RNA in Urine May Detect Bladder Cancer and Distinguish Response.
Cancer Discov. 2026 Nov 20:OF1. doi: 10.1158/2159-8290.CD-RW2026.
PubMed
Targeting neutral sphingomyelinase enhances NK cell-mediated immunity via the
CXCL10-CXCR3 axis in murine bladder cancer cells.
Cancer Immunol Immunother. 2026;75:288.
PubMed
Abstract available
Identification of Immune-Associated Hub Genes Related to the G2/M Checkpoint
Pathway in Bladder Cancer Through Integrated Bioinformatics Analysis.
Cancer Inform. 2026;25:11769351261500680.
PubMed
Abstract available
The HDAC2/KAT2A-Lamin A lactylation axis regulates tumor progression and
chemoresistance in bladder cancer.
Cancer Lett. 2026;664:218968.
PubMed
Abstract available
Lactylation-driven NOP2 stabilization suppresses ferroptosis to promote cisplatin
resistance via enhancing m5C-Dependent GLS1 mRNA stability in bladder cancer.
Cancer Lett. 2026 Nov 19:218989. doi: 10.1016/j.canlet.2026.218989.
PubMed
Abstract available
Prognostic Significance of Adverse Histopathological Features in Early-Onset
Bladder Urothelial Carcinoma After Radical Cystectomy: A Propensity Score-Matched
Analysis.
Cancer Med. 2026;15:e72500.
PubMed
Abstract available
Revealing the Invisible: Circulating and Urinary Tumor DNA in Bladder Cancer.
Cancers (Basel). 2026;18:3566.
PubMed
Abstract available
Tumor-myeloid crosstalk drives therapy resistance in localized bladder cancer.
Cell Press Blue. 2026;1:100100.
PubMed
Abstract available
Retraction notice to "Downregulation of integrin-linked kinase inhibits
epithelial-to-mesenchymal transition and metastasis in bladder cancer cells"
[Cell. Signal. 24 (2012) 1323-1332].
Cell Signal. 2026 Nov 18:112992. doi: 10.1016/j.cellsig.2026.112992.
PubMed
A Case of Confirmed Diagnosis of Wild-Type Transthyretin Cardiac Amyloidosis from
a Bladder Cancer Resection Specimen.
CJC Open. 2026;8:1526-1529.
PubMed
Spatial Immune Organization Associates with Response to CD40 Agonism in
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: A Phase I Trial.
Clin Cancer Res. 2026 Nov 17. doi: 10.1158/1078-0432.CCR-26-3256.
PubMed
Abstract available
Histological Subtypes, Divergent Differentiation, and Neuroendocrine Components
in Primary Non-Muscle-Invasive Bladder Cancer Managed with Bladder-Preserving
Approaches: A Propensity Score-Matched Study.
Clin Genitourin Cancer. 2026 Oct 26:102703. doi: 10.1016/j.clgc.2026.102703.
PubMed
Abstract available
Clin Med Insights Arthritis Musculoskelet Disord
Unusual Presentation of Metastatic Bladder Cancer: A Case Report of
Acrometastasis to the Hand and Review of the Literature.
Clin Med Insights Arthritis Musculoskelet Disord. 2026.
PubMed
Abstract available
Comput Methods Biomech Biomed Engin
Machine learning-driven construction and validation of an intra-tumoral
heterogeneity-associated prognostic model for bladder urothelial carcinoma.
Comput Methods Biomech Biomed Engin. 2026;29:3541-3553.
PubMed
Abstract available
Adding immune checkpoint inhibitors to bladder-preservation therapy in
muscle-invasive bladder cancer: A systematic review and meta-analysis.
Crit Rev Oncol Hematol. 2026;229:105701.
PubMed
Abstract available
From Stage to Systems: Integrating Standard Laboratory Markers into Bladder
Cancer Prognostic Models.
Diagnostics (Basel). 2026;16:3486.
PubMed
Abstract available
Eugenol Suppresses Heavy Metal-Induced Proliferation of Urinary Bladder Cancer
Cells Through Modulation of DNA Demethylation and Activation of the Intrinsic
Apoptotic Pathway.
Environ Toxicol. 2026 Nov 16. doi: 10.1002/tox.70209.
PubMed
Abstract available
TP53 Sequence Variant Profiling in Moroccan Patients with Non-Metastatic Bladder
Cancer: Analysis of Exons 4-9.
Fr J Urol. 2026 Nov 19:103290. doi: 10.1016/j.fjurol.2026.103290.
PubMed
Abstract available
French AFU Cancer Committee Guidelines - Update 2026-2028: Muscle-invasive
bladder tumors (MIBC).
Fr J Urol. 2026;36:103192.
PubMed
Abstract available
French AFU Cancer Committee Guidelines - Update 2026-2028: Non-muscle-invasive
bladder tumors (NMIBC).
Fr J Urol. 2026;36:103182.
PubMed
Abstract available
Cancer-associated fibroblasts and extracellular matrix remodeling driving drug
resistance and immune evasion in bladder cancer: research progress.
Front Immunol. 2026;17:1941274.
PubMed
Abstract available
[Recent Advances in ctDNA and utDNA Research for Bladder Cancer].
Gan To Kagaku Ryoho. 2026;53:683-688.
PubMed
Abstract available
Charting the landscape of microbiota in bladder cancer: Molecular mechanisms and
therapeutic implications.
Genes Dis. 2026;14:102270.
PubMed
Abstract available
Adrenal Insufficiency After Preoperative Enfortumab Vedotin Plus Pembrolizumab in
Locally Advanced Bladder Cancer: A Case Report.
IJU Case Rep. 2026;9:e70292.
PubMed
Abstract available
Clinical Utility of lncRNAs in Urothelial Carcinoma of the Bladder: Diagnostics,
Risk Stratification, and Treatment Guidance.
Int J Mol Sci. 2026;27:9461.
PubMed
Abstract available
Phospho-LATS1/2 Immunoreactivity and Survival in Muscle-Invasive Bladder Cancer:
A Quantitative Immunohistochemical Study.
Int J Urol. 2026;33:e70715.
PubMed
Abstract available
Predictors of residual tumour and recurrence in high-grade NMIBC: insights from a
multicenter re-TURBT cohort.
Int Urol Nephrol. 2026;58:5215-5221.
PubMed
Abstract available
BRAFV595E mutation detected across the disease spectrum from non-neoplastic
urothelium to invasive urothelial carcinoma in dogs.
J Am Vet Med Assoc. 2026;264.
PubMed
Abstract available
Role of Radical Cystectomy in Metastatic Bladder Cancer.
J Clin Med. 2026;15:8586.
PubMed
Abstract available
Preoperative Systemic Inflammatory Indices (SII, SIRI and PIV) Associated with
Adverse Histology and 12-Month Recurrence After Transurethral Resection of
Non-Muscle-Invasive Bladder Cancer.
J Clin Med. 2026;15:8536.
PubMed
Abstract available
Study Rationale, Enrollment Characteristics, and Central Review of Clinical
Stage: The INTACT Randomized Clinical Trial.
JAMA Netw Open. 2026;9:e2644122.
PubMed
Abstract available
A Bayesian reanalysis of the THOR trial cohort 1 using reconstructed individual
patient data: interval-specific effects and clinically interpretable estimands
under non-proportional hazards.
Jpn J Clin Oncol. 2026;56:1437-1442.
PubMed
Abstract available
Prognostic Significance of AI-Quantified Central Tumor-Infiltrating Lymphocytes
in Bladder Cancer.
Lab Invest. 2026 Nov 20:106183. doi: 10.1016/j.labinv.2026.106183.
PubMed
Abstract available
MR Clinics-Nuclear Medicine in Renal, Adrenal, Bladder and Urothelial
Malignancies.
Magn Reson Imaging Clin N Am. 2027;35:63-77.
PubMed
Abstract available
Evaluation of a KLH-conjugated uroplakin 3A-derived peptide formulation in an
OH-BBN bladder cancer model.
Med Oncol. 2026;43:388.
PubMed
Abstract available
Tetrahydrocurcumin suppresses bladder cancer progression by modulating
SPP1-associated M2 macrophage-tumor interaction.
Mol Biomed. 2026;7:252.
PubMed
Abstract available
Enfortumab Vedotin and Pembrolizumab for Cisplatin-Eligible Bladder Cancer.
N Engl J Med. 2026;395:2073.
PubMed
Enfortumab Vedotin and Pembrolizumab for Cisplatin-Eligible Bladder Cancer.
N Engl J Med. 2026;395:2073-2074.
PubMed
Enfortumab Vedotin and Pembrolizumab for Cisplatin-Eligible Bladder Cancer.
Reply.
N Engl J Med. 2026;395:2074-2075.
PubMed
Fluke-borne viruses are a risk factor and diagnostic target for diseases caused
by carcinogenic trematodes.
Nat Commun. 2026;17:11707.
PubMed
Abstract available
[Retracted] Genipin inhibits the growth of human bladder cancer cells via
inactivation of PI3K/Akt signaling.
Oncol Lett. 2026;33:14.
PubMed
Abstract available
Molecular mechanisms of Schistosoma haematobium-associated bladder carcinogenesis
and urinary biomarkers for early diagnosis: A review.
PLoS Negl Trop Dis. 2026;20:e0014868.
PubMed
Abstract available
Spectral CT for Assessing Local Tumor Invasion in Bladder Cancer.
Radiol Imaging Cancer. 2026;8:e260451.
PubMed
Transcriptomic profiling of tropomyosin isoforms in bladder cancer:
multi-platform sequencing and experimental validation.
Sci Rep. 2026;16:37672.
PubMed
Abstract available
Alcohol use reduces the efficacy of anti-PD1 immunotherapy by disrupting
antitumor immunity.
Sci Signal. 2026;19:eaef1375.
PubMed
Abstract available
Best Evidence for Bladder Function Exercise in Patients With Bladder Cancer
Following Orthotopic Neobladder Reconstruction.
Semin Oncol Nurs. 2026;43:152415.
PubMed
Abstract available
Sichuan Da Xue Xue Bao Yi Xue Ban
[Predictive Performance of an Ultrasound Blood Perfusion Parameter-Based Model
for Postoperative Prognosis of Patients With Bladder Cancer].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2026;57:1514-1520.
PubMed
Abstract available
Perioperative Systemic Therapies for Muscle-Invasive Bladder Cancer: An Updated
Systematic Review and Network Meta-analysis.
Target Oncol. 2026 Nov 18. doi: 10.1007/s11523-026-01270.
PubMed
Abstract available
Circulating tumor DNA as a tool for precision management in bladder cancer: A
narrative review.
Ther Adv Urol. 2026;18:17562872261493705.
PubMed
Abstract available
Machine learning-based prediction of BCG NON-RESPONSE in high-risk
NON-muscle-invasive bladder cancer: An exploratory single-centre cohort study.
Ther Adv Urol. 2026;18:17562872261493691.
PubMed
Abstract available
Hydrogel-Based Therapies for Bladder Cancer: Intravesical Delivery,
Immunomodulation, and Precision.
Tissue Eng Part B Rev. 2026 Nov 18:19373368261506151.
PubMed
Abstract available
The CALLY Index as an Independent Predictor of Survival in Bladder Cancer
Patients Undergoing Radical Cystectomy: A Multicenter Study.
Urol Int. 2026 Nov 16:aewag059. doi: 10.1159.
PubMed
Abstract available
Re: Development and validation of a computational histology artificial
intelligence-powered prognostic biomarker in muscle-invasive bladder cancer.
Urol Oncol. 2026 Nov 20:S1078-1439(26)00775.
PubMed
Intraoperative indocyanine green fluorescence guidance to reduce ureteroenteric
anastomotic strictures during robot-assisted radical cystectomy. A systematic
review and meta-analysis.
Urol Oncol. 2026;44:998-1006.
PubMed
Abstract available
CDKL1 facilitates tumorigenesis and metastasis of bladder urothelial carcinoma by
activating SIRT1/Wnt/beta-catenin signaling.
Urol Oncol. 2026;44:1007-1022.
PubMed
Abstract available
Performance of the EORTC and CUETO risk prediction models in contemporary
patients undergoing transurethral resection of bladder tumor with blue light
cystoscopy.
Urol Oncol. 2026;44:1023-1032.
PubMed
Abstract available
Postoperative progression-free survival and clinicopathological risk
stratification in urachal carcinoma: A multicenter retrospective cohort study.
Urol Oncol. 2026;44:887-896.
PubMed
Abstract available
Prehabilitation for patients undergoing radical cystectomy: Patient selection and
targeted interventions.
Urol Oncol. 2026;44:911-920.
PubMed
Abstract available
Lymphovascular invasion and nodal positivity may identify candidates for adjuvant
nivolumab in high-risk muscle-invasive urothelial carcinoma.
Urol Oncol. 2026;44:931-938.
PubMed
Abstract available
Is all gross hematuria high risk? Age-stratified outcomes after anticoagulation
initiation using a large claims database.
Urol Oncol. 2026;44:969-976.
PubMed
Abstract available
FOXP2/FABP4 axis promotes bladder cancer aggressiveness by driving lipid
metabolic reprogramming to activate FAK/Src signaling.
Urol Oncol. 2026 Nov 13:S1078-1439(26)00770.
PubMed
Abstract available
Reply to "Editorial Comment on "Analyzing Trends in Management of Intravesical
Therapy-Associated Lower Urinary Tract Symptoms for Patients Treated for
Non-muscle Invasive Bladder Cancer.
Urology. 2026 Nov 18:S0090-4295(26)00729-6. doi: 10.1016/j.urology.2026.
PubMed
Editorial Comment on "Analyzing Trends in Management of Intravesical
Therapy-Associated Lower Urinary Tract Symptoms for Patients Treated for
Non-muscle Invasive Bladder Cancer".
Urology. 2026 Nov 13:S0090-4295(26)00721-1. doi: 10.1016/j.urology.2026.
PubMed
Decoding hypoxia-driven microenvironment remodeling in bladder cancer reveals
TPST1 as a key driver of metastasis.
World J Surg Oncol. 2026;24:439.
PubMed
Abstract available
Does neoadjuvant or induction systemic therapy modify the association between
pelvic lymph node dissection metrics and survival after radical cystectomy for
bladder cancer? A systematic review and meta-analysis.
World J Surg Oncol. 2026;24:427.
PubMed
Abstract available
Unlocking a TP53 mutation-specific vulnerability: the miR-486-3p/CYB561 axis in
bladder cancer.
World J Surg Oncol. 2026;24:434.
PubMed
Abstract available
Detection of recurrence after surgical treatment for urachal adenocarcinoma:
diagnostic yield of cystoscopy, imaging and serum tumor markers.
World J Urol. 2026;44:803.
PubMed
Abstract available
Outcomes of robot-assisted cystectomy and intracorporeal ileal conduit diversion
in radiotherapy-exposed patients: propensity-score matched analysis.
World J Urol. 2026;44:827.
PubMed
Abstract available
Efficacy of HER2-targeted therapies in localized urothelial carcinoma: a
systematic review and meta-analysis.
World J Urol. 2026;44:810.
PubMed
Abstract available
Urinary biomarker-guided surveillance versus standard cystoscopic surveillance
for non-muscle-invasive bladder cancer: a systematic review and meta-analysis of
randomized controlled trials.
World J Urol. 2026;44:811.
PubMed
Abstract available
Thank you for your interest in scientific medicine.